We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy.
- Authors
Eilers Jr., R. E.; Gandhi, M.; Patel, J. D.; Mulcahy, M. F.; Agulnik, M.; Hensing, T.; Lacouture, Mario E.
- Abstract
Background: Patients treated with epidermal growth factor receptor inhibitors (EGFRIs) frequently experience dermatologic toxic effects. Whereas the impact of these effects on quality of life and EGFRI dosing has been described, their impact on physical health has not been ascertained. We examined the prevalence of infections that complicate dermatologic toxic effects of EGFRIs.
- Subjects
CANCER patients; SKIN diseases; QUALITY of life; EPIDERMAL growth factor; CHEMICAL inhibitors
- Publication
JNCI: Journal of the National Cancer Institute, 2010, Vol 102, Issue 1, p47
- ISSN
0027-8874
- Publication type
Article
- DOI
10.1093/jnci/djp439